US Patent 7816372 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Patent 7816372 was granted and assigned to Ligand Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ligand Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7816372

Date of Patent

October 19, 2010

Patent Application Number

10566569

Date Filed

August 23, 2004

Patent Primary Examiner

‌

D. Margaret Seaman

Patent abstract

The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by AR. Also provided are methods of making such compounds and pharmaceutical compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7816372 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API